{
    "eid": "2-s2.0-85044405851",
    "title": "A multicentre, randomised controlled study of enteric-coated mycophenolate sodium for the treatment of relapsed or resistant proliferative lupus nephritis: An Asian experience",
    "cover-date": "2016-01-01",
    "subject-areas": [
        {
            "$": "Rheumatology",
            "@code": "2745"
        },
        {
            "$": "Immunology",
            "@code": "2403"
        }
    ],
    "keywords": [
        "Cyclophosphamide",
        "Infections",
        "Lupus Nephritis",
        "Treatment"
    ],
    "authors": [
        "Sirirat Anutrakulchai"
    ],
    "citedby-count": 10,
    "ref-count": 36,
    "ref-list": [
        "Lupus nephritis: Pathologic features, epidemiology and a guide to therapeutic decisions",
        "Diagnosis and treatment of lupus nephritis flares - An update",
        "Overview of lupus nephritis management guidelines and perspective from Asia",
        "Systematic review of the epidemiology of systemic lupus erythematosus in the asia-pacific region: Prevalence, incidence, clinical features, and mortality",
        "Lupus nephritis: Current update",
        "Treatment of lupus nephritis: Practical issues in Asian countries",
        "Revised classification of lupus nephritis is valuable in predicting renal outcome with an indication of the proportion of glomeruli affected by chronic lesions",
        "Classification of lupus nephritis",
        "Clinical, biochemical and pathological predictors of poor response to intravenous cyclophosphamide in patients with proliferative lupus nephritis",
        "Lupus Nephritis in Thailand: Clinicopathologic findings and outcome in 569 patients",
        "Lupus nephritis: Treatment of resistant disease",
        "Renal flares are common in patients with severe proliferative lupus nephritis treated with pulse immunosuppressive therapy: Long-term followup of a cohort of 145 patients participating in randomized controlled studies",
        "'Nephritic flares' are predictors of bad long-term renal outcome in lupus nephritis",
        "Lupus nephritis flares",
        "Induction and maintenance treatment of proliferative lupus nephritis: A meta-analysis of randomized controlled trials",
        "Mycophenolate mofetil is as efficacious as, but safer than, cyclophosphamide in the treatment of proliferative lupus nephritis: A meta-analysis and meta-regression",
        "Long-term data on corticosteroids and mycophenolate mofetil treatment in lupus nephritis",
        "Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis",
        "Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: Results from the MAINTAIN Nephritis Trial",
        "Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis",
        "Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis",
        "Randomized controlled trial of pulse intravenous cyclophosphamide versus mycophenolate mofetil in the induction therapy of proliferative lupus nephritis",
        "Maintenance therapies for proliferative lupus nephritis: Mycophenolate mofetil, azathioprine and intravenous cyclophosphamide",
        "Is mycophenolate mofetil superior to pulse intravenous cyclophosphamide for induction therapy of proliferative lupus nephritis in Egyptian patients?",
        "Sequential Therapies for Proliferative Lupus Nephritis",
        "A cost-utility analysis of alternative drug regimens for newly diagnosed severe lupus nephritis patients in Thailand",
        "Mycophenolate mofetil therapy in lupus nephritis: Clinical observations",
        "The safety and efficacy of MMF in lupus nephritis: A pilot study",
        "Efficacy of enteric-coated mycophenolate sodium in patients with resistant-type lupus nephritis: A prospective study",
        "Mycophenolate in refractory and relapsing lupus nephritis",
        "Mycophenolate mofetil for systemic lupus erythematosus refractory to other immunosuppressive agents",
        "Lupus nephritis: Treatment with mycophenolate mofetil",
        "Treatment for lupus nephritis: A revisit",
        "Therapy of Lupus Nephritis",
        "Therapeutic drug monitoring of mycophenolate mofetil for the treatment of severely active lupus nephritis"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Khon Kaen",
            "affilname": "Khon Kaen University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Khon Kaen",
            "affilname": "Khon Kaen Regional Hospital",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Pathum Thani",
            "affilname": "Thammasat University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Phramongkutklao College of Medicine",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": null,
            "affilname": "Medical University Research Network of the Consortium of Thai Medical Schools (MedResNet)",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Nopparat Rajathani Hospital",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Health Intervention and Technology Assessment Program",
        "Chulalongkorn University"
    ]
}